Form 4: KBR Director Lynn A. Dugle Reports Acquisition of 3,521 Shares of Common Stock
SEC Form 4 Filing
Director Lynn A. Dugle reports acquiring 3,521 shares of KBR, Inc. common stock on February 27, 2025, through restricted stock units.
Summary
- On February 27, 2025, Lynn A. Dugle, a director of KBR, Inc., acquired 3,521 shares of common stock.
- The acquisition was through restricted stock units, which will convert to common stock on a 1-to-1 ratio.
- The price per share was $0.00.
- 100% of the restricted stock units will vest 6 months after the grant date.
- Following the transaction, Dugle beneficially owns 23,601 shares of KBR common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment.
Positives
- A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The restricted stock units will vest 6 months after the grant date, converting to common stock on a 1-to-1 basis.
Industry Context
Form 4 filings are routine disclosures required by the SEC when company insiders, such as directors and officers, trade their company's stock. These filings provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The acquisition of shares by a director could have a slightly positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of transaction: Acquisition of 3,521 shares of common stock. |
| 02/28/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.